Xuan Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cancer-related molecular mechanisms research 4
-
- Epigenetics and DNA Methylation 4
- Circular RNAs in diseases 4
- Melanoma and MAPK Pathways 2
- Co-authors
- Chuanyuan Wei (10 shared papers)Rui Peng (8 shared papers)Jia‐Cheng Lu (8 shared papers)Jia Fan (10 shared papers)Pengfei Zhang (5 shared papers)Guo‐Ming Shi (10 shared papers)Chao Gao (5 shared papers)Xiaoyong Huang (6 shared papers)
- Journals
- Journal of Neurochemistry (2 papers)Cell Death and Disease (2 papers)Molecular Cancer (2 papers)Journal of Cellular and Molecular Medicine (1 paper)Clinical Epigenetics (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xuan Yang
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 84
- Cancer Research 379
- Hepatology 193
- Molecular Biology 676
- Oncology 218
- Neurology 62
Countries citing papers authored by Xuan Yang
This map shows the geographic impact of Xuan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Yang more than expected).
Fields of papers citing papers by Xuan Yang
This network shows the impact of papers produced by Xuan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Yang. The network helps show where Xuan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 219 | |
| 2 | 2020 | 185 | |
| 3 | 2019 | 180 | |
| 4 | 2022 | 138 | |
| 5 | 2019 | 132 | |
| 6 | 2014 | 123 | |
| 7 | 2019 | 63 | |
| 8 | 2011 | 51 | |
| 9 | 2018 | 48 | |
| 10 | 2019 | 46 | |
| 11 | 2018 | 43 | |
| 12 | 2018 | 42 | |
| 13 | 2017 | 41 | |
| 14 | 2021 | 38 | |
| 15 | 2019 | 37 | |
| 16 | 2023 | 30 | |
| 17 | 2019 | 29 | |
| 18 | 2017 | 28 | |
| 19 | Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4. | 2018 | 25 |
| 20 | 2019 | 25 |
About Xuan Yang
Xuan Yang is a scholar working on Cancer Research, Molecular Biology, Neurology, Oncology and Hepatology, having authored 37 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Epigenetics and DNA Methylation (4 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Neurological Disorders and Treatments (3 papers), Melanoma and MAPK Pathways (2 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Cancer Research (379 citations), Hepatology (193 citations), Molecular Biology (676 citations), Oncology (218 citations) and Neurology (62 citations). Xuan Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Chuanyuan Wei, Rui Peng, Jia‐Cheng Lu, Jia Fan, Pengfei Zhang, Guo‐Ming Shi, Chao Gao, Xiaoyong Huang, Ai‐Wu Ke and Jiabin Cai. Their work appears in journals such as Journal of Neurochemistry, Cell Death and Disease, Molecular Cancer, Journal of Cellular and Molecular Medicine and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.